Global and Japan Hemophilia Drugs Market Insights, Forecast to 2026

Global and Japan Hemophilia Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Hemophilia Drugs Product Introduction
1.2 Market Segments
1.3 Key Hemophilia Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hemophilia Drugs Market Size Growth Rate by Type
1.4.2 Hemophilia A
1.4.3 Inhibitors
1.4.4 Hemophilia B
1.4.5 Von Willebrand Disease
1.5 Market by Application
1.5.1 Global Hemophilia Drugs Market Size Growth Rate by Application
1.5.2 Recombinant Therapies
1.5.3 Plasma-Derived Therapies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hemophilia Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hemophilia Drugs Revenue 2015-2026
2.1.2 Global Hemophilia Drugs Sales 2015-2026
2.2 Global Hemophilia Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Hemophilia Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Hemophilia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Hemophilia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Hemophilia Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Hemophilia Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Hemophilia Drugs Revenue Forecast by Region (2021-2026)
3 Global Hemophilia Drugs Competitor Landscape by Players
3.1 Global Top Hemophilia Drugs Sales by Manufacturers
3.1.1 Global Hemophilia Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Hemophilia Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Hemophilia Drugs Manufacturers by Revenue
3.2.1 Global Hemophilia Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Hemophilia Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hemophilia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hemophilia Drugs Revenue in 2019
3.2.5 Global Hemophilia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hemophilia Drugs Price by Manufacturers
3.4 Global Hemophilia Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hemophilia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemophilia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hemophilia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hemophilia Drugs Market Size by Type (2015-2020)
4.1.1 Global Hemophilia Drugs Sales by Type (2015-2020)
4.1.2 Global Hemophilia Drugs Revenue by Type (2015-2020)
4.1.3 Hemophilia Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hemophilia Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hemophilia Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hemophilia Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hemophilia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hemophilia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hemophilia Drugs Market Size by Application (2015-2020)
5.1.1 Global Hemophilia Drugs Sales by Application (2015-2020)
5.1.2 Global Hemophilia Drugs Revenue by Application (2015-2020)
5.1.3 Hemophilia Drugs Price by Application (2015-2020)
5.2 Hemophilia Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hemophilia Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hemophilia Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hemophilia Drugs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Hemophilia Drugs Market Size YoY Growth 2015-2026
6.1.1 Japan Hemophilia Drugs Sales YoY Growth 2015-2026
6.1.2 Japan Hemophilia Drugs Revenue YoY Growth 2015-2026
6.1.3 Japan Hemophilia Drugs Market Share in Global Market 2015-2026
6.2 Japan Hemophilia Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Hemophilia Drugs Players by Sales (2015-2020)
6.2.2 Japan Top Hemophilia Drugs Players by Revenue (2015-2020)
6.3 Japan Hemophilia Drugs Historic Market Review by Type (2015-2020)
6.3.1 Japan Hemophilia Drugs Sales Market Share by Type (2015-2020)
6.3.2 Japan Hemophilia Drugs Revenue Market Share by Type (2015-2020)
6.3.3 Japan Hemophilia Drugs Price by Type (2015-2020)
6.4 Japan Hemophilia Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Hemophilia Drugs Sales Forecast by Type (2021-2026)
6.4.2 Japan Hemophilia Drugs Revenue Forecast by Type (2021-2026)
6.4.3 Japan Hemophilia Drugs Price Forecast by Type (2021-2026)
6.5 Japan Hemophilia Drugs Historic Market Review by Application (2015-2020)
6.5.1 Japan Hemophilia Drugs Sales Market Share by Application (2015-2020)
6.5.2 Japan Hemophilia Drugs Revenue Market Share by Application (2015-2020)
6.5.3 Japan Hemophilia Drugs Price by Application (2015-2020)
6.6 Japan Hemophilia Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Hemophilia Drugs Sales Forecast by Application (2021-2026)
6.6.2 Japan Hemophilia Drugs Revenue Forecast by Application (2021-2026)
6.6.3 Japan Hemophilia Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Hemophilia Drugs Market Size YoY Growth 2015-2026
7.2 North America Hemophilia Drugs Market Facts & Figures by Country
7.2.1 North America Hemophilia Drugs Sales by Country (2015-2020)
7.2.2 North America Hemophilia Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Hemophilia Drugs Market Size YoY Growth 2015-2026
8.2 Europe Hemophilia Drugs Market Facts & Figures by Country
8.2.1 Europe Hemophilia Drugs Sales by Country
8.2.2 Europe Hemophilia Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Hemophilia Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Hemophilia Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Hemophilia Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Hemophilia Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Hemophilia Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Hemophilia Drugs Market Facts & Figures by Country
10.2.1 Latin America Hemophilia Drugs Sales by Country
10.2.2 Latin America Hemophilia Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hemophilia Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Hemophilia Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Hemophilia Drugs Sales by Country
11.2.2 Middle East and Africa Hemophilia Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Baxalta
12.1.1 Baxalta Corporation Information
12.1.2 Baxalta Description and Business Overview
12.1.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Baxalta Hemophilia Drugs Products Offered
12.1.5 Baxalta Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Description and Business Overview
12.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Hemophilia Drugs Products Offered
12.2.5 Bayer Recent Development
12.3 CSL Behring
12.3.1 CSL Behring Corporation Information
12.3.2 CSL Behring Description and Business Overview
12.3.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSL Behring Hemophilia Drugs Products Offered
12.3.5 CSL Behring Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Hemophilia Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 Alnylam Pharmaceuticals
12.5.1 Alnylam Pharmaceuticals Corporation Information
12.5.2 Alnylam Pharmaceuticals Description and Business Overview
12.5.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Alnylam Pharmaceuticals Hemophilia Drugs Products Offered
12.5.5 Alnylam Pharmaceuticals Recent Development
12.6 BioMarin
12.6.1 BioMarin Corporation Information
12.6.2 BioMarin Description and Business Overview
12.6.3 BioMarin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BioMarin Hemophilia Drugs Products Offered
12.6.5 BioMarin Recent Development
12.7 Catalyst Biosciences
12.7.1 Catalyst Biosciences Corporation Information
12.7.2 Catalyst Biosciences Description and Business Overview
12.7.3 Catalyst Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Catalyst Biosciences Hemophilia Drugs Products Offered
12.7.5 Catalyst Biosciences Recent Development
12.8 Dimension Therapeutics
12.8.1 Dimension Therapeutics Corporation Information
12.8.2 Dimension Therapeutics Description and Business Overview
12.8.3 Dimension Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Dimension Therapeutics Hemophilia Drugs Products Offered
12.8.5 Dimension Therapeutics Recent Development
12.9 F. Hoffmann-La Roche
12.9.1 F. Hoffmann-La Roche Corporation Information
12.9.2 F. Hoffmann-La Roche Description and Business Overview
12.9.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.9.4 F. Hoffmann-La Roche Hemophilia Drugs Products Offered
12.9.5 F. Hoffmann-La Roche Recent Development
12.10 Grifols
12.10.1 Grifols Corporation Information
12.10.2 Grifols Description and Business Overview
12.10.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Grifols Hemophilia Drugs Products Offered
12.10.5 Grifols Recent Development
12.11 Baxalta
12.11.1 Baxalta Corporation Information
12.11.2 Baxalta Description and Business Overview
12.11.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Baxalta Hemophilia Drugs Products Offered
12.11.5 Baxalta Recent Development
12.12 Sangamo Biosciences
12.12.1 Sangamo Biosciences Corporation Information
12.12.2 Sangamo Biosciences Description and Business Overview
12.12.3 Sangamo Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sangamo Biosciences Products Offered
12.12.5 Sangamo Biosciences Recent Development
12.13 Spark Therapeutics
12.13.1 Spark Therapeutics Corporation Information
12.13.2 Spark Therapeutics Description and Business Overview
12.13.3 Spark Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Spark Therapeutics Products Offered
12.13.5 Spark Therapeutics Recent Development
12.14 Swedish Orphan Biovitrum
12.14.1 Swedish Orphan Biovitrum Corporation Information
12.14.2 Swedish Orphan Biovitrum Description and Business Overview
12.14.3 Swedish Orphan Biovitrum Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Swedish Orphan Biovitrum Products Offered
12.14.5 Swedish Orphan Biovitrum Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hemophilia Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemophilia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Hemophilia Drugs Market Segments
Table 2. Ranking of Global Top Hemophilia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hemophilia Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Hemophilia A
Table 5. Major Manufacturers of Inhibitors
Table 6. Major Manufacturers of Hemophilia B
Table 7. Major Manufacturers of Von Willebrand Disease
Table 8. Global Hemophilia Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Hemophilia Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Hemophilia Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Hemophilia Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Hemophilia Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Hemophilia Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 14. Global Hemophilia Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Hemophilia Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Hemophilia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Hemophilia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Drugs as of 2019)
Table 18. Hemophilia Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Hemophilia Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Hemophilia Drugs Price (2015-2020) (USD/MT)
Table 21. Hemophilia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hemophilia Drugs Product Type
Table 23. Date of International Manufacturers Enter into Hemophilia Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 26. Global Hemophilia Drugs Sales Share by Type (2015-2020)
Table 27. Global Hemophilia Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Hemophilia Drugs Revenue Share by Type (2015-2020)
Table 29. Hemophilia Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Hemophilia Drugs Sales Share by Type (2021-2026)
Table 31. Global Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 32. Global Hemophilia Drugs Sales Share by Application (2015-2020)
Table 33. Global Hemophilia Drugs Sales Share by Application (2021-2026)
Table 34. Global Hemophilia Drugs Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Hemophilia Drugs Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Hemophilia Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 37. Japan Hemophilia Drugs Sales (K MT) of Key Companies (2015-2020)
Table 38. Japan Hemophilia Drugs Sales Share by Company (2015-2020)
Table 39. Japan Hemophilia Drugs Revenue (US$ Million) by Company (2015-2020)
Table 40. Japan Hemophilia Drugs Sales (K MT) by Type (2015-2020)
Table 41. Japan Hemophilia Drugs Sales Share by Type (2015-2020)
Table 42. Japan Hemophilia Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Japan Hemophilia Drugs Price (K MT) by Type (2015-2020)
Table 44. Japan Hemophilia Drugs Sales (K MT) by Type (2021-2026)
Table 45. Japan Hemophilia Drugs Sales Share by Type (2021-2026)
Table 46. Japan Hemophilia Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Japan Hemophilia Drugs Revenue Share by Type (2021-2026)
Table 48. Japan Hemophilia Drugs Price (K MT) by Type (2021-2026)
Table 49. Japan Hemophilia Drugs Sales (K MT) by Application (2015-2020)
Table 50. Japan Hemophilia Drugs Sales Share by Application (2015-2020)
Table 51. Japan Hemophilia Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Japan Hemophilia Drugs Sales (K MT) by Application (2021-2026)
Table 53. Japan Hemophilia Drugs Sales Share by Application (2021-2026)
Table 54. Japan Hemophilia Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Japan Hemophilia Drugs Revenue Share by Application (2021-2026)
Table 56. North America Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 57. North America Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 58. North America Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 60. Europe Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 61. Europe Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 62. Europe Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Hemophilia Drugs Sales by Region (2015-2020) (K MT)
Table 65. Asia Pacific Hemophilia Drugs Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Hemophilia Drugs Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Hemophilia Drugs Revenue Market Share by Region (2015-2020)
Table 68. Latin America Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 69. Latin America Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 76. Baxalta Corporation Information
Table 77. Baxalta Description and Business Overview
Table 78. Baxalta Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Baxalta Hemophilia Drugs Product
Table 80. Baxalta Recent Development
Table 81. Bayer Corporation Information
Table 82. Bayer Description and Business Overview
Table 83. Bayer Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Bayer Product
Table 85. Bayer Recent Development
Table 86. CSL Behring Corporation Information
Table 87. CSL Behring Description and Business Overview
Table 88. CSL Behring Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. CSL Behring Product
Table 90. CSL Behring Recent Development
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Business Overview
Table 93. Pfizer Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Pfizer Product
Table 95. Pfizer Recent Development
Table 96. Alnylam Pharmaceuticals Corporation Information
Table 97. Alnylam Pharmaceuticals Description and Business Overview
Table 98. Alnylam Pharmaceuticals Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Alnylam Pharmaceuticals Product
Table 100. Alnylam Pharmaceuticals Recent Development
Table 101. BioMarin Corporation Information
Table 102. BioMarin Description and Business Overview
Table 103. BioMarin Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. BioMarin Product
Table 105. BioMarin Recent Development
Table 106. Catalyst Biosciences Corporation Information
Table 107. Catalyst Biosciences Description and Business Overview
Table 108. Catalyst Biosciences Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Catalyst Biosciences Product
Table 110. Catalyst Biosciences Recent Development
Table 111. Dimension Therapeutics Corporation Information
Table 112. Dimension Therapeutics Description and Business Overview
Table 113. Dimension Therapeutics Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Dimension Therapeutics Product
Table 115. Dimension Therapeutics Recent Development
Table 116. F. Hoffmann-La Roche Corporation Information
Table 117. F. Hoffmann-La Roche Description and Business Overview
Table 118. F. Hoffmann-La Roche Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. F. Hoffmann-La Roche Product
Table 120. F. Hoffmann-La Roche Recent Development
Table 121. Grifols Corporation Information
Table 122. Grifols Description and Business Overview
Table 123. Grifols Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Grifols Product
Table 125. Grifols Recent Development
Table 126. Octapharma Corporation Information
Table 127. Octapharma Description and Business Overview
Table 128. Octapharma Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Octapharma Product
Table 130. Octapharma Recent Development
Table 131. Sangamo Biosciences Corporation Information
Table 132. Sangamo Biosciences Description and Business Overview
Table 133. Sangamo Biosciences Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Sangamo Biosciences Product
Table 135. Sangamo Biosciences Recent Development
Table 136. Spark Therapeutics Corporation Information
Table 137. Spark Therapeutics Description and Business Overview
Table 138. Spark Therapeutics Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Spark Therapeutics Product
Table 140. Spark Therapeutics Recent Development
Table 141. Swedish Orphan Biovitrum Corporation Information
Table 142. Swedish Orphan Biovitrum Description and Business Overview
Table 143. Swedish Orphan Biovitrum Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Swedish Orphan Biovitrum Product
Table 145. Swedish Orphan Biovitrum Recent Development
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Hemophilia Drugs Players
Table 150. Hemophilia Drugs Customers List
Table 151. Hemophilia Drugs Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia Drugs Product Picture
Figure 2. Global Hemophilia Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Hemophilia A Product Picture
Figure 4. Inhibitors Product Picture
Figure 5. Hemophilia B Product Picture
Figure 6. Von Willebrand Disease Product Picture
Figure 7. Global Hemophilia Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Recombinant Therapies
Figure 9. Plasma-Derived Therapies
Figure 10. Hemophilia Drugs Report Years Considered
Figure 11. Global Hemophilia Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Hemophilia Drugs Sales 2015-2026 (K MT)
Figure 13. Global Hemophilia Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Hemophilia Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Hemophilia Drugs Sales Market Share by Region in 2019
Figure 16. Global Hemophilia Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Hemophilia Drugs Revenue Market Share by Region in 2019
Figure 18. Global Hemophilia Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Hemophilia Drugs Revenue in 2019
Figure 20. Hemophilia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Hemophilia Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Hemophilia Drugs Sales Market Share by Type in 2019
Figure 23. Global Hemophilia Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Hemophilia Drugs Revenue Market Share by Type in 2019
Figure 25. Global Hemophilia Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Hemophilia Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Hemophilia Drugs Sales Market Share by Application in 2019
Figure 28. Global Hemophilia Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Hemophilia Drugs Revenue Market Share by Application in 2019
Figure 30. Japan Hemophilia Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 31. Japan Hemophilia Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. Japan Hemophilia Drugs Market Share in Global Market 2015-2026
Figure 33. Japan 5 and 10 Largest Hemophilia Drugs Players Market Share by Revenue in Hemophilia Drugs in 2019
Figure 34. Japan Hemophilia Drugs Revenue Share by Type (2015-2020)
Figure 35. Japan Hemophilia Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Japan Hemophilia Drugs Revenue Share by Application (2015-2020)
Figure 37. Japan Hemophilia Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 39. North America Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Hemophilia Drugs Sales Market Share by Country in 2019
Figure 41. North America Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 42. U.S. Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. U.S. Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Canada Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Hemophilia Drugs Sales Market Share by Country in 2019
Figure 49. Europe Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 61. Asia Pacific Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Hemophilia Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Hemophilia Drugs Revenue Market Share by Region in 2019
Figure 64. China Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. China Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. Japan Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. South Korea Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. India Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Australia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Taiwan Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Indonesia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Thailand Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Malaysia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Philippines Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Vietnam Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Hemophilia Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Hemophilia Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Hemophilia Drugs Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs